Select Medical
SEM was delisted on the 30th of June, 2026.
252 hedge funds and large institutions have $3.76B invested in Select Medical in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 86 increasing their positions, 95 reducing their positions, and 44 closing their positions.
427% more call options, than puts
Call options by funds: $1.96M | Put options by funds: $373K
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
0.58% less ownership
Funds ownership: 77.75% → 77.17% (-0.58%)
9% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 95
5% less funds holding
Funds holding: 264 → 252 (-12)
15% less capital invested
Capital invested by funds: $4.43B → $3.76B (-$666M)
20% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$72.4M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$29.6M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$19.1M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$16.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$9.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$30.8M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
-$25.3M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$22.6M |
| 4 |
Goldman Sachs
New York
|
-$18M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$16M |
SEM Hedge Fund Activity: Q3 2021 in Review
252 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2021, worth a combined $3.76B — down 15% from $4.43B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of SEM and 35 opened new positions — a net loss of 9 holders — while 95 trimmed existing stakes and 86 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $72.4M. The largest seller was Assenagon Asset Management, exiting entirely with an estimated $30.8M sold.
- 252 institutional investors held Select Medical (SEM) as of Q3 2021, down from 264 in Q2 2021.
- Funds reported $3.76B of Select Medical stock for Q3 2021, down 15% quarter-over-quarter.
- 35 funds opened new Select Medical positions in Q3 2021 and 44 closed out, a net change of -9 holders.
- The largest Select Medical buyer in Q3 2021 was T. Rowe Price Associates, an estimated $72.4M added.
- The largest Select Medical seller in Q3 2021 was Assenagon Asset Management, an estimated $30.8M sold.
Based on aggregated 13F filings for Q3 2021.